
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 13.850 | 13.850 | 0.000 |
Shares | 86.470 | 86.470 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.872 | 22.347 |
Price to Book | 2.822 | 2.714 |
Price to Sales | 2.680 | 3.330 |
Price to Cash Flow | 15.759 | 16.400 |
Dividend Yield | 2.833 | 2.102 |
5 Years Earnings Growth | 6.759 | 6.822 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.630 | 97.797 |
Consumer Defensive | 1.160 | 1.757 |
Basic Materials | 0.180 | 0.472 |
Technology | 0.020 | 0.380 |
Industrials | 0.010 | 0.563 |
Number of long holdings: 84
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.52 | 50.27 | -1.68% | |
Kelun Pharm A | CNE100000PW7 | 5.65 | 33.14 | -6.60% | |
Dong-E E-Jiao A | CNE0000006Y9 | 5.03 | 61.23 | -2.96% | |
Cr Sanjiu A | CNE0000011K8 | 4.81 | 42.87 | -2.23% | |
Huadong Med A | CNE0000011S1 | 4.73 | 37.62 | -4.08% | |
Beigene | CNE100005XT6 | 4.40 | 239.00 | -1.88% | |
Salubris Pharm A | CNE100000FW8 | 4.38 | 39.65 | +0.51% | |
KPC Pharm | CNE0000015P8 | 4.04 | 16.94 | -3.42% | |
Yuyue Medical A | CNE1000009X3 | 3.85 | 33.21 | -3.26% | |
WuXi AppTec | CNE1000031K4 | 3.63 | 57.36 | +1.67% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBCCS Innovation Power Eq | 5.74B | -2.16 | 6.64 | -1.21 | ||
ICBC Credit Literary Ids Eq | 5.6B | 8.23 | 2.87 | - | ||
ICBCCS China Core Value Mixed A | 4.05B | -1.35 | -5.51 | 3.00 | ||
SZSE Dividend Exchange Trade | 1.48 | -0.28 | 4.76 | |||
ICBCCS MedicalHlth Care Sect Secs I | 2.64B | 8.25 | -8.77 | 5.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review